Clinical supply chain procurement challenges in 2024

  • Overview of evolving challenges and solutions in clinical supply chain procurement
  • Examination of the impact of the geopolitical and geoeconomic climate on procurement
  • Regulatory considerations and compliance challenges in clinical supply chain management

Next generation biotherapeutics: bacteria as a novel drug delivery device

  • Non-pathogenic, non-replicative, immune protected bacteria engineered to safely deliver biologic therapeutic payloads intracellular to targeted tissues
  • Bacteria capable of delivering biologics as in mRNA, siRNA, proteins/nanobodies, and CRISPR/Cas, independent of size
  • Reaches tissues that cannot be targeted by viral vectors or lipid nanoparticles
  • Efficiently target even hard-to-reach tissues and tumors
  • Revolutionizes future of treatment by ensuring better outcomes for patients

Leveraging technology to ease patient burden: the right solutions for better clinical trials

  • Discover the technology behind patient-centric trials: explore the cutting-edge tools that streamline trial processes and minimize patient burden, improving both retention and outcomes
  • The smart use of tech in clinical trials: learn how to strategically implement technology to enhance patient experiences without compromising data integrity or trial efficiency.
  • Balancing innovation with human touch: understand when technology empowers clinical trials and when human intervention remains critical, ensuring the right blend for successful studies.
  • Practical insights on reducing patient burden: gain actionable insights into how technology can be applied to simplify patient participation, from remote monitoring to decentralized trial designs
  • Where tech truly makes an impact: explore specific phases and aspects of clinical trials where technology transforms patient engagement and drives trial success